These results suggest that drebrin expression in bladder cancer tissue may work in conjunction with progranulin levels as a novel biomarker for bladder cancer and may identify tumors likely to progress to the invasive phenotype. The gene discussed is DBN1; the disease is urinary bladder cancer.